Prescription Drug Price Transparency Act
- Last Action
- 2/7/2019
Actions
- 2019-02-07Referred to the Subcommittee on Health.
- 2019-02-07Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2019-02-07Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2019-02-07Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2019-02-07Introduced in House
- 2019-02-07Introduced in House
CRS Summary
As of 2019-02-07 (00)
Prescription Drug Price Transparency Act
This bill establishes additional requirements for prescription drug plan sponsors (PDPs) under Medicare and Medicare Advantage, as well as health insurance carriers under the Federal Employees Health Benefits Program, relating to the methodology of payments to pharmacies and the use of pharmacy benefits managers (PBMs).
Specifically, such PDPs and carriers must disclose specified information to pharmacies regarding applicable standards for reimbursement that are based on drug costs, including the sources used to update such standards. Additionally, such PDPs and carriers may not contract with PBMs that require, or that provide an incentive for, plan enrollees to use pharmacies that have a shared ownership interest with the PBM.
Cosponsors (20)
- David Loebsack (D-IA)
- David Roe (R-TN)
- Bruce Westerman (R-AR)
- Kathleen Rice (D-NY)
- Steve King (R-IA)
- Yvette Clarke (D-NY)
- Austin Scott (R-GA)
- Jody Hice (R-GA)
- Filemon Vela (D-TX)
- Jamie Raskin (D-MD)
- Cathy Rodgers (R-WA)
- Peter Welch (D-VT)
- Earl Carter (R-GA)
- Eric Crawford (R-AR)
- COLLIN PETERSON (D-MN)
- Bradley Byrne (R-AL)
- Dan Newhouse (R-WA)
- Jaime Herrera Beutler (R-WA)
- Vicente Gonzalez (D-TX)
- Roger Marshall (R-KS)
Subjects
- Administrative remedies
- Consumer affairs
- Contracts and agency
- Health care costs and insurance
- Health information and medical records
- Insurance industry and regulation
- Medical ethics
- Medicare
- Prescription drugs
- Public contracts and procurement
- Retail and wholesale trades
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.